Publication:
F-18-FDG PET/CT Findings of Myeloid Sarcoma in the Pancreas

dc.contributor.authorsFilizoglu, Nuh; Ozguven, Salih
dc.date.accessioned2022-03-10T11:20:02Z
dc.date.accessioned2026-01-11T13:27:19Z
dc.date.available2022-03-10T11:20:02Z
dc.date.issued2022
dc.description.abstractMyeloid sarcoma (MS) is a rare neoplasm of leukemic cells that infiltrates an extramedullary soft tissue. MS may present at initial diagnosis of any myeloproliferative disease or relapse after treatment. It is most commonly associated with acute myeloid leukemia. The incidence of pancreatic involvement of MS is very rare. Herein we present FDG PET/CT findings of a rare case of MS involving the pancreas, which was initially misdiagnosed as pancreatic carcinoma.
dc.identifier.doi10.1097/RLU.0000000000003736
dc.identifier.eissn1536-0229
dc.identifier.issn0363-9762
dc.identifier.pubmed34034332
dc.identifier.urihttps://hdl.handle.net/11424/219727
dc.identifier.wosWOS:000727998400028
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofCLINICAL NUCLEAR MEDICINE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectmyeloid sarcoma
dc.subjectpancreas
dc.subjectFDG
dc.subjectGa-68-DOTATATE
dc.subjectPET/CT
dc.subjectGRANULOCYTIC SARCOMA
dc.titleF-18-FDG PET/CT Findings of Myeloid Sarcoma in the Pancreas
dc.typeeditorial
dspace.entity.typePublication
oaire.citation.endPageE53
oaire.citation.issue1
oaire.citation.startPageE52
oaire.citation.titleCLINICAL NUCLEAR MEDICINE
oaire.citation.volume47

Files